PROPERMAB is an AI model developed by Regeneron (United States), first published in October 2024. It works in the biology domain, on tasks such as antibody property prediction.
Epoch AI has no training-compute estimate for this model.
The reference paper has 4 citations. Epoch AI rates the confidence of this record as confident.